Literature DB >> 21788956

New experimental rabbit animal model for cervical spondylotic myelopathy.

G Klironomos1, S Karadimas, A Mavrakis, P Mirilas, I Savvas, E Papadaki, D J Papachristou, G Gatzounis.   

Abstract

STUDY
DESIGN: Cervical spondylotic myelopathy (CSM) represents the most commonly acquired cause of spinal cord dysfunction among individuals over 55 years old. The pathophysiology of the disease involves static and dynamic mechanical factors, which are the result of chronic degeneration. The clinical course of the disease remains unpredictable. In the past, many experimental animal models have been developed to study the cellular and molecular mechanisms underlining the pathophysiology of the disease.
OBJECTIVES: To create a new animal model of CSM, which will reproduce the temporal course of the disease and the local microenvironment at the site of spinal cord compression.
METHODS: We performed posterior laminectomy to New Zealand rabbits at the level of C7, and a thin sheet (5-7 μm) of aromatic polyether was implanted with microsurgical technique at the epidural space underneath C5-C6 laminae. Motor function evaluation was performed after the operation and once a week thereafter.
RESULTS: After 20 weeks, the animals were killed, and the histological evaluation of spinal cord at the site of compression above and below it, using eosin hematoxylin, immonohistochemistry and Kluver-Barrera techniques reveals axonal swelling and demyelination, interstitial edema and myelin sheet fragmentation. Moreover, histological evaluation of C5 and C6 laminae reveals osteophyte formation.
CONCLUSION: We believe that this CSM model reproduces the temporal evolution of the disease and creates a local microenvironment at the site of spinal cord compression, which shares the same characteristics with that of human disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21788956     DOI: 10.1038/sc.2011.71

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  6 in total

1.  Role of MK2 signaling pathway in the chronic compression of cervical spinal cord.

Authors:  Hongxing Song; Xiutong Fang; Mingjie Wen; Fang Yu; Kai Gao; Chenli Sun; Zhenwei Wang
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060

2.  Proteomic analysis of cerebrospinal fluid in canine cervical spondylomyelopathy.

Authors:  Paula Martin-Vaquero; Ronaldo C da Costa; Matthew J Allen; Sarah A Moore; Jeremy K Keirsey; Kari B Green
Journal:  Spine (Phila Pa 1976)       Date:  2015-05-01       Impact factor: 3.468

3.  Progressive spinal cord compression technique in experimental rabbit animal model for cervical spondylotic myelopathy.

Authors:  Sabri Ibrahim; Wibi Riawan
Journal:  Ann Med Surg (Lond)       Date:  2021-07-28

Review 4.  Pathobiology of cervical spondylotic myelopathy.

Authors:  Spyridon K Karadimas; Georgios Gatzounis; Michael G Fehlings
Journal:  Eur Spine J       Date:  2014-03-14       Impact factor: 3.134

5.  Degenerative Cervical Myelopathy; A Review of the Latest Advances and Future Directions in Management.

Authors:  Jamie R F Wilson; Jetan H Badhiwala; Ali Moghaddamjou; Allan R Martin; Michael G Fehlings
Journal:  Neurospine       Date:  2019-08-26

6.  The Pathophysiology of Degenerative Cervical Myelopathy and the Physiology of Recovery Following Decompression.

Authors:  Farhana Akter; Xinming Yu; Xingping Qin; Shun Yao; Parisa Nikrouz; Yasir Syed; Mark Kotter
Journal:  Front Neurosci       Date:  2020-04-30       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.